These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17526378)

  • 41. [Perspectives for the immunotherapy of condylomata].
    Bourgault Villada I
    Ann Dermatol Venereol; 2000; 127(10 Suppl):3S23-3S25. PubMed ID: 11116860
    [No Abstract]   [Full Text] [Related]  

  • 42. Candidate vaccines for immunotherapy in HIV.
    Gotch FM; Imami N; Hardy G
    HIV Med; 2001 Oct; 2(4):260-5. PubMed ID: 11737407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD8 T cell anti-HIV activity as a complementary protective mechanism in vaccinated chimpanzees.
    Leno M; Kowalski M; Robert-Guroff M
    AIDS; 2000 May; 14(7):893-4. PubMed ID: 10839598
    [No Abstract]   [Full Text] [Related]  

  • 44. [HIV infection].
    Cordero GC
    Sidahora; 1995; ():10-2. PubMed ID: 11363196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes.
    Kloverpris H; Karlsson I; Bonde J; Thorn M; Vinner L; Pedersen AE; Hentze JL; Andresen BS; Svane IM; Gerstoft J; Kronborg G; Fomsgaard A
    AIDS; 2009 Jul; 23(11):1329-40. PubMed ID: 19528789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unraveling the strands of HIV's web.
    Pantaleo G
    Nat Med; 1999 Jan; 5(1):27-8. PubMed ID: 9883835
    [No Abstract]   [Full Text] [Related]  

  • 47. Autologous and allogenic systems of HIV expansion: what is the better choice for clinical application in therapeutic vaccine?
    Silva LT; Pontillo A; da Silva WC; Almeida Ad; Duarte AJ; Oshiro TM
    Immunotherapy; 2013 Dec; 5(12):1305-11. PubMed ID: 24283841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine.
    López A; van der Lubbe N; Sánchez-Palomino S; Arnedo M; Nomdedeu M; Castro P; Guilà M; Maleno MJ; García F; Gallart T; Gatell JM; Plana M
    Vaccine; 2009 Oct; 27(44):6166-78. PubMed ID: 19712765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How do HIV elite controllers do what they do?
    Saag M; Deeks SG
    Clin Infect Dis; 2010 Jul; 51(2):239-41. PubMed ID: 20550453
    [No Abstract]   [Full Text] [Related]  

  • 50. Novel T-cell-based vaccines via arming polyclonal CD4
    Xu A; Freywald A; Xiang J
    Immunotherapy; 2016 Nov; 8(11):1265-1269. PubMed ID: 27993084
    [No Abstract]   [Full Text] [Related]  

  • 51. Inclusion of the viral anti-apoptotic molecule M11L in DNA vaccine vectors enhances HIV Env-specific T cell-mediated immunity.
    Su J; Willert C; Comanita L; Peters A; Gilbert PA; Strathdee C; O'Connell PJ; McFadden GD; Dekaban GA
    Virology; 2008 May; 375(1):48-58. PubMed ID: 18291435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Virus immunocapture provides evidence of CD8 lymphocyte-derived HIV-1 in vivo.
    Hughes GJ; Willey SJ; Cochrane A; Leen C; Bell JE; Simmonds P
    AIDS; 2007 Jul; 21(12):1507-13. PubMed ID: 17630544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD4+ T lymphocytes and cryoglobulins in patients coinfected with HIV and hepatitis C virus: forgetting the hidden CD4+ cell subsets.
    Perrella A; Atripaldi L; Sbreglia C; Borgia G; Sorrentino P; Tarantino G; Perrella O
    Clin Infect Dis; 2005 Jun; 40(11):1707-8; author reply 1708-9. PubMed ID: 15889382
    [No Abstract]   [Full Text] [Related]  

  • 54. HIV-1/AIDS vaccine development: are we in the darkness.
    Qiu C; Xu JQ
    Chin Med J (Engl); 2008 May; 121(10):939-45. PubMed ID: 18706210
    [No Abstract]   [Full Text] [Related]  

  • 55. HIV controllers: how do they tame the virus?
    Sáez-Cirión A; Pancino G; Sinet M; Venet A; Lambotte O;
    Trends Immunol; 2007 Dec; 28(12):532-40. PubMed ID: 17981085
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic HIV vaccines show promise.
    Abbott A
    Nature; 2010 Jul; 466(7306):539. PubMed ID: 20671679
    [No Abstract]   [Full Text] [Related]  

  • 57. FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection.
    Ndhlovu LC; Loo CP; Spotts G; Nixon DF; Hecht FM
    J Leukoc Biol; 2008 Feb; 83(2):254-62. PubMed ID: 17982112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measuring HIV-1-specific T cell immunity: how valid are current assays?
    D'Souza MP; Altfeld M
    J Infect Dis; 2008 Feb; 197(3):337-9. PubMed ID: 18184092
    [No Abstract]   [Full Text] [Related]  

  • 59. [Different sensitivity of productively HIV-I infected and non-infected cells to apoptosis].
    Boĭchuk SV; Ivanov AV; Mustafin Ig; Makarova MV; Dunaev PD; Aleksander L
    Patol Fiziol Eksp Ter; 2008; (4):7-9. PubMed ID: 19198264
    [No Abstract]   [Full Text] [Related]  

  • 60. Modelling the influence of activation-induced apoptosis of CD4+ and CD8+ T-cells on the immune system response of a HIV-infected patient.
    Stan GB; Belmudes F; Fonteneau R; Zeggwagh F; Lefebvre MA; Michelet C; Ernst D
    IET Syst Biol; 2008 Mar; 2(2):94-102. PubMed ID: 18397120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.